Insmed Inc. buy Royal Bank of Canada
Start price
19.03.25
/
50%
€71.50
Target price
19.03.26
€91.44
Performance (%)
32.17%
Price
08.08.25
€93.00
Summary
This prediction is currently active. The BUY prediction by Royal_Bank_of_Canada for Insmed Inc. has seen massive gains of 32.17%. This prediction currently runs until 19.03.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Insmed Inc. | -0.535% | -0.535% |
| iShares Core DAX® | 3.109% | -0.124% |
| iShares Nasdaq 100 | 3.088% | 4.723% |
| iShares Nikkei 225® | 4.760% | 5.051% |
| iShares S&P 500 | 1.840% | 3.430% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Insmed Inc. diskutieren
Insmed Incorporated (NASDAQ: INSM) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $100.00 price target on the stock.
Ratings data for INSM provided by MarketBeat